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CXCL10 is part of the group of interferon-stimulated genes and it plays an important role during different
viral infections by inducing cell activation, chemotaxis and lymphocyte priming toward the Th1 pheno-
type. In this study, we investigated in vitro the effects of CXCL10 in activated human primary T lympho-
cytes in terms of apoptosis or survival, and delineated the signaling pathways that are involved. CXCL10,
in combination with IL-2 and/or IFNa, induces apoptosis in T lymphocytes. Moreover, CXCL10-induced
activation of CXCR3 also triggers pro-survival signals that can be blocked by pertussis toxin. The analysis
of the downstream signaling kinases shows that apoptosis is p38 MAPK-dependent and the pro-survival
signals rely on the sustained activation of PI3K and the transient activation of Akt. On the other hand, the
transient activation of p44/p42 ERK did not have an impact on T lymphocyte survival. We propose an
immunological model in which CXCL10, together with other co-stimulating cytokines, participates in
the activation of T lymphocytes, promotes survival and expansion of certain lymphocyte subsets, and
induces chemotaxis toward the infected tissues. On the other hand, CXCL10 might contribute to the trig-
gering of apoptosis in other subsets of T lymphocytes, including those lymphocytes that were transiently
activated but later lacked the appropriate sets of speciﬁc co-stimulating signals to ensure their survival.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
CXCL10 (IFNc-inducible protein of 10 kDa or IP10) plays an
important role during viral infections such as inﬂuenza [1], SARS
coronavirus [2], HIV [3] and West Nile virus [4]. Although initially
identiﬁed to be an IFNc-responsive gene, a number of different
cytokines including IFNa/b are capable of inducing CXCL10 expres-
sion in diverse cell types. The chemokines CXCL4, CXCL9 (Mig),
CXCL10 (IP-10), and CXCL11 (I-TAC) bind the receptor CXCR3 and
exert a potent chemotactic effect on activated T lymphocytes [5];
however, CXCL10 is the one that plays the most prominent role
during the antiviral responses. CXCR3 is expressed on 35–40% of
normal blood T cells and its expression is enhanced by treatment
[6] with IL-2. Additionally, CXCR3 is expressed on other cell types
such as natural killer cells (NKs), eosinophils, B lymphocytes, and
different epithelial and endothelial cell types. CXCR3 is a receptor
that is coupled to a G protein-signaling pathway. Binding of che-
mokines to CXCR3 activates G protein-mediated signaling and re-
sults in downstream activation of phospholipase C (PLC), kinasemental Therapeutics, Toronto
3rd Floor room 913, Toronto,
: +1 416 581 7606.
C-ND license.A and C, formation of phosphatidyl inositol-1,4,5-triphophate,
and also the increase of intracellular calcium ions [7]. Despite the
functional diversity of the cells that can express CXCR3, the down-
stream activation seems to be quite homogeneous, involving p44/
p42 ERK, Akt, PI3K and p38 [5,8,9]. However, the effects of CXCR3
activation are very diverse, ranging from chemotaxis in T lympho-
cytes [8,10,11] and airway epithelial cells [9] to anti-proliferation
in human embryonic kidney cells [10] and induction of apoptosis
in acinar cells [12].
Programmed cell death (apoptosis) is an active process mor-
phologically characterized by shrinkage of the cell, nuclear frag-
mentation, chromatin condensation and chromosomal DNA
fragmentation [13]. Apoptosis plays an essential role in tissue
development and is required for maintaining tissue homeostasis
[14]. Although apoptosis can be triggered by many different stim-
uli, executioner caspases always participate in the organized deg-
radation of the cellular organelles; when activated, executioner
caspases cleave a variety of cytoplasmic and nuclear proteins
including caspases themselves and their downstream substrates
[15] through controlled proteolysis [16]. Induction of apoptosis
is a tightly regulated process and it is the balance between pro-
survival and pro-apoptosis signals that eventually determines
the fate of the cells [17]. Vlahakis et al. have shown that G pro-
tein-coupled chemokine receptors can activate both the survival
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that CXCL10 can trigger apoptosis in several cellular models, such
as acinar cells [12], neurons [19], HeLa cells [20] and microvascu-
lar endothelial cells [21]; however, the role of CXCL10 in deter-
mining survival or death in blood T lymphocytes remains largely
unknown.
In this study, we have delineated critical signaling pathways
activated by CXCL10 and its receptor CXCR3. We demonstrated
that CXCL10 is able to transiently activate the Akt and p44/42
ERK signaling cascades and sustainably activate p38 MAPK signal-
ing in primary human T lymphocytes. Moreover, we determined
the role that these pathways have in the induction of either apop-
tosis or cell survival.2. Materials and methods
2.1. Antibodies and reagents
The monoclonal antibodies (MAb) mouse anti-human Akt,
mouse anti-human phospho-Akt, mouse anti-human CXCR3,
mouse anti-human CD4, CD8, CD20, and mouse anti-human actin,
were obtained from BD Biosciences (San Diego, CA, USA). Mouse
anti-human p38, rabbit anti-human phospho-p38, rabbit anti-hu-
man p44/42 ERK, rabbit anti-human phospho-p44/42 ERK, rabbit
anti-human phospho-Bcl2, rabbit anti-human Bcl2, rabbit anti-hu-
man caspase 3 (CASP3), and cleaved CASP3 were obtained from
Cell Signaling Technology (Boston, MA, USA). SYBRGreen PCR
Master Mix was obtained from Applied Biosystems (Foster City,
CA, USA). Goat anti-mouse IgG-HRP and donkey anti-rabbit IgG-
HRP were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA. USA). Recombinant CXCL10, IL-2, and IFNa protein were pur-
chased from R&D Systems (Minneapolis, MN). RPMI-1640 supple-
mented with 2 mM L-glutamine HEPES Buffer solution, and
0.005% (w/v) gentamycin was obtained from GIBCO BRL (Burling-
ton, Ontario, Canada). Fetal calf serum (FCS) was purchased from
Cansera (Rexdale, Ontario, Canada) and heat-inactivated at 56 C
for 30 min upon arrival. The PI3K inhibitor (wortmannin), Phos-
phate-buffered saline (PBS) pH 7.4 and Pertussis toxin were ob-
tained from Sigma, Aldrich Inc. (Oakville, Ontario, Canada). The
MEK inhibitor (PD98059) and the p38 inhibitor (SB202190) were
purchased from Biosource International Inc. (Camarillo, CA, USA).2.2. Isolation of peripheral blood mononuclear cells (PBMCs)
Blood was obtained from healthy donors with ages ranging
from 23 to 40 years old. Density gradient centrifugation was used
to separate PBMCs from human blood. First, approximately 60 ml
of blood were collected from the brachial vein of a healthy human
volunteer using a 28-gauge needle and a sterile 60 ml syringe con-
taining 50–100 units sodium heparin (Becton–Dickinson, Mississa-
uga, Ontario) per ml blood. Next 20 ml sterile PBS containing
penicillin and streptomycin (Pen/Strep) (GIBCO BRL) (2 ml/50 ml
PBS) was added to 20 ml blood in a sterile 50 mL centrifuge tube.
The tube was underlayed with 7 ml of sterile ﬁcoll-Hypaque
1077 (Sigma–Aldrich Inc.) and centrifuged at 400 g for 45 min at
room temperature. Using a transfer pipette, approximately 5 ml
of plasma was removed and discarded. Using a fresh sterile transfer
pipette, the PBMC layer was transferred to a fresh 50 ml tube. The
tube was tilted at a 45-degree angle to facilitate removal of the
PBMC layer and 45 ml PBS-pen/strep was added to the isolated
PBMCs. The PBMC sample was centrifuged at 400 g for 10 min
and the supernatant was discarded. The resulting cell pellet was
gently resuspended in approximately 3 ml of PBS-pen/strep.
5–10 ml of sterile distilled water was added before swirling for a
maximum of 10–15 s to lyse the RBCs. Finally, 30 ml of PBS wereimmediately added and the resuspended cells were centrifuged
again for 10 min at 300–400 g to remove lysed RBCs and any
remaining ﬁcoll.
2.3. Isolation and culture of human T lymphocytes
For the study of CXCR3 expression, lymphocytes were separated
from PBMCs by magnetic beads positive selection using the Mono-
cyte Isolation Kit II (Miltenyi Biotech, Auburn, CA). In all the other
experiments, untouched T lymphocytes were separated from
PBMCs using the Pan T Cell Isolation Kit II (Miltenyi). Cells were
resuspended in PBS and centrifuged for 10 min at 300–400 g. The
supernatant was discarded and the cells resuspended in 5–10 ml
complete RPMI-1640 medium supplemented with 10% of heat
inactivated FCS, 2 mM L-glutamine (Fisher Scientiﬁc, Nepean, On-
tario, Canada), 0.1 mM b-mercaptoethanol (Fisher Scientiﬁc) and
pen/strep. The cells were counted using Unopettes (Becton Dickin-
son and company, Franklin Lake, NJ, USA) and a hemocytometer
and the desired cell concentration was prepared by dilution with
complete RPMI medium. To induce expression of CXCR3, lympho-
cytes were cultured for 10 days in complete RPMI 1640 medium
with different combinations of IL-2 (400 U/ml), IFNa (5000 U/ml)
and CXCL10 (50 nM); cells received cytokine re-treatment every
3 days. Selected T cell cultures were preincubated for 1 hour at
37 C with inhibitors such as pertussis toxin (1 lg/ml), wortman-
nin (100 nM), PD9809 (10 lM), SB203580 (10 lM) before the addi-
tion of CXCL10 + IL-2 + IFNa. All experiments were performed in
triplicate.
2.4. Flow cytometry
Lymphocyte cells were pelleted by centrifugation, resuspended
in 0.1% BSA in PBS, aliquotted into FACS tubes, and incubated with
antibody for 30 min in the dark. To detect apoptotic cells, the sam-
ples were incubated with Annexin V-PE in a buffer containing 7-
Amino-actinomycin (7-AAD) (BD Biosciences, San Diego, CA) and
analyzed by FACS. Stained cells were washed in 2 ml PBS ﬁxed in
2% paraformaldehyde in PBS, and analyzed using a dual-laser ﬂow
cytometer (FACS Calibur, Becton Dickinson, San Jose, CA) and Cell-
Quest Software (BD Biosciences). Post-acquisition cytometry data
was analyzed using FlowJo v. 5.7.2 (TreeStar, Inc., Ashland, OR).
2.5. RNA extraction and quantitative real-time PCR
After 10 days of culture, cells were pelleted by centrifugation at
300 g, lysed by addition of 1 ml TRIZOL reagent (Invitrogen Can-
ada) per 5–10  106 cells and the RNA was extracted according to
the manufacture’s protocol. The concentration of RNA was mea-
sured as optical density (OD) at 260 nm using an Eppendorf
Biophotometer (Mississauga, Ontario, Canada). The integrity and
quality of total RNA was conﬁrmed by RNase-free agarose gel elec-
trophoresis using DEPC-treated TAE buffer. Quantitative real time-
PCR (QRT-PCR) was performed using an ABI-PRISM 7900HT
Sequence Detection System and SYBR green PCR Master Mix
(Applied Biosystems, Foster City, California). Total RNA (250–
1000 ng) was reverse transcribed in a 20 ll reaction under the
following conditions: 6.25 lM random hexanucleotide primer (Ap-
plied Biosystems), 50 mM TrisHCl pH 8.3, 3 mMMgCl2, 75 mM KCl,
500 lM dATP, dGTP, dTTP, and dCTP, 10 mM DTT and 200U Super-
Script II RNAse H-reverse transcriptase, at 42 C for 60 min using a
thermal cycler (PTC-150 Minicycler, MJ Research-Bio-Rad Labora-
tories Canada Ltd., Mississauga, Ontario). The resulting cDNA was
subjected either to conventional PCR ampliﬁcation or QRT-PCR.
Each QRT-PCR reaction was performed in a volume of 10 ll with
0.125 ll cDNA, primer pair and 5 ll of SYBR green PCR Master
Mix in ABI-PRISM optical 384 well plates. Primer pairs were
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100 bp using Primer Express v2.0 software (Applied Biosystems).
Each primer pair was tested with a logarithmic dilution of cDNA
to generate a standard curve, which was used to calculate the start-
ing quantity of target RNA. Primers speciﬁc for 18S rRNA were used
as an endogenous standard to normalize samples. Fold-changes
were calculated by dividing the normalized post-treated sample
quantity with the normalized pre-treated control quantity. 50–30
sequences of primer pairs were as follows: CXCL10-forward-TCC
ACG TGT TGA GAT CAT TGC, reverse-TCT TGA TGG CCT TCG ATT
CTG, 18S-rRNA-forward-CGG CTA CCA CAT CCA AGG AA, reverse-
GCT GGA ATT ACC GCG GCT.Fig. 1. CXCR3 expression on human T cells is enhanced by IL-2 but not induced by CX
positive selection (Monocyte Isolation Kit II, Miltenyi Biotech) and cultured in the absenc
CXCL10 (D). Phenotypic ﬂow cytometry analysis was performed to assess CXCR3, CD8, C
viable cell populations are indicated within the panels, where the cutoff is determined b
PE. The results are representative of three independent experiments. Gates were based2.6. Cell lysis and protein extraction
Lymphocytes were cultured in 24 well plates at 37 C and, fol-
lowing the treatments indicated in their respective ﬁgure legends
(Figs. 3–5 and Supp. Fig. 3), reactions were terminated by centrifu-
gation, followed by supernatant aspiration and cell resuspension in
50 ll of ice-cold lysis buffer (20 mM Tris (pH 7.4), 137 mM NaCl,
1 mM MgCl2, 1 mM CaCl2, 10% glycerol (w/v), 1% Nonidet P-40
(w/v), and protease inhibitors, 1 mM PMSF, 2 lg/ml aprotinin,
2 lg/ml leupeptin, 2 lg/ml pepstatin A, and tyrosine phosphotase
inhibitor, 1 mM sodium orthovanadate). Lysates were incubated
on a rotator for 20 min, and non-soluble material was removedCL10. Lymphocytes were puriﬁed from healthy donor PBMCs using magnetic bead
e of IL-2 (A), the presence of IL-2 (B), the absence of CXCL10 (C) and the presence of
D84, and CD20 expression at the protein level. Percentages of CXCR3+ cells on gated
y negative controls obtained by isotype-matched control antibody conjugated with
on the isotype controls.
Fig. 2. Recombinant CXCL10-induced apoptosis in T cells. (A) Primary T lymphocytes were treated with CXCL10 and analyzed by FACS for apoptosis. (B) Primary lymphocytes
were treated with IL2, IFNa and CXCL10 and analyzed by FACS for apoptosis. (C) Primary lymphocytes were treated with IL-2, IFNa and CXCL10 and analyzed by FACS for
apoptosis using BD Annexin-V Apoptosis Detection Kit. Statistical signiﬁcance, respect to isotype control: p < 0.05 and p < 0.01; respect to IL-2 only: p < 0.05 and p < 0.01;
respect to IL-2 + IFNa: ++p < 0.01. Gates were based on the isotype controls. (D) Activation of p38 MAPK in T lymphocytes induces activation of caspase 3. Protein extracts
derived from lysates from T cells treated with different combinations of IL-2, IFNa, and CXCL10, were subjected to western blot analysis using antibodies that recognize full-
length (p32) and cleaved (p19, p17, p12) caspase 3. The protein level of actin was examined as a loading control.
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supernatants were determined by Bradford protein assay (Bio-
Rad) and adjusted to equal protein concentration between samples
by dilution with lysis buffer.
2.7. Immunoblotting
Cell lysates were boiled for 5 min in Laemmli buffer and sam-
ples were loaded onto 4–14% SDS–PAGE gels (Bio-Rad) and the
protein was separated by electrophoresis. The protein was trans-
ferred onto nitrocellulose membranes by semi-dry electroblotting.
Immunoblotting was performed as previously described (42).
Brieﬂy, membranes were incubated for 1 hour with blocking solu-
tion (5% nonfat milk/0.05% sodium azide in TBS (10 mM Tris (pH
7.5) and 100 mM NaCl)) and then incubated overnight in the re-
quired dilution of the appropriate primary antibody in TBS/0.1%
Tween-20. After washing twice, membranes were incubated with
goat anti-mouse or donkey anti-rabbit horseradish peroxidase-
conjugated secondary antibodies. Protein bands were detected
with enhanced chemiluminescence (ECL) (Amersham-Pharmacia
Biotech) and directly quantiﬁed using an image station (Bio-Rad,
Hercules, CA). Where necessary, membranes were stripped for
re-probing by incubation in stripping buffer (62.5 mM Tris (pH
6.8), 2% SDS, and 100 mM 2-ME) at room temperature for 30 min.
3. Results
3.1. IL-2, but neither CXCL10 nor IFNa, increases the expression of
CXCR3 on human T lymphocytes
We examined the effects of IL-2 and CXCL10 on the expression
of CXCR3 in human primary lymphocytes using ﬂow cytometry.
CXCR3 was found to be expressed on untreated lymphocytes, how-
ever, we cannot rule out the possibility that the expression levelsof CXCR3 were altered, up to some extent, during the initial process
of positive cell selection. Upon treatment with IL-2, primary lym-
phocytes showed greatly enhanced expression of CXCR3. The in-
crease in CXCR3 expression occurred in the CD8+ population, but
not in CD4+ or CD20+ cells (Fig. 1A, B and E). However, incubation
with CXCL10 did not alter the expression levels of CXCR3 (Fig. 1C–
E). We also showed that the expression of CXCR3 is not induced by
concentrations of IFNa up to 15,000 U/ml in neither CD4+ nor CD8+
cells (Supp. Fig. 1). Using real time PCR, we showed that CXCL10 is
induced by IFNa both in primary lymphocytes and human embry-
onic kidney cells (HEK239) (Supp. Fig. 2), ensuring that T lympho-
cytes were responsive to IFNa under our experimental conditions.
3.2. CXCL10 in combination with IL-2 and/or IFNa, induces caspase 3-
mediated apoptosis in primary T lymphocytes
We examined the rate of cell death induced in primary T
lymphocytes after incubation with CXCL10 alone (50 nM) after
16 h. FACS analysis of cells stained with Annexin V and 7-AAD
demonstrated that treatment of CXCR3-positive T cells with re-
combinant CXCL10 induces early apoptosis (Annexin V positive,
7-AAD negative), although to a very limited extent (Fig. 2A). Fur-
thermore, pre-incubation of T cells with IL-2 (400 U/ml), which in-
creases CXCR3 expression but not apoptosis rates (Fig. 2B and C),
enhanced CXCL10-induced early apoptosis dramatically (Fig. 4C).
Cell incubation with IFNa alone (5000 U/ml) also leads to T cell
early apoptosis. Moreover, the highest rates of early apoptosis
were observed with simultaneous treatment with CXCL10 + IL-
2 + IFNa (Fig. 2C). The cytokine treatments that were tested also
produced increased necrosis rates (Annexin V positive, 7-AAD
positive) in parallel with the observed rates of early apoptosis
(Fig. 2A and B). To determine whether the cell death was
CASP3-mediated, we analyzed whole cell lysates from T lympho-
cytes treated with CXCL10 + IL-2 + IFNa; the presence of active
Fig. 3. CXCL10 induces sustainable phosphorylation of p38 MAPK in CXCR3-positive T cells. (A) Histogram analysis of intracellular staining of p-p38 in CXCR3 positive
lymphocytes (left) and mean ﬂuorescent intensity of p-p38 in T cells (right). Freshly isolated human T cells were cultured in medium alone, or treated with IL-2, IFNa, or
CXCL10 or a combination of the three, for the times indicated. Cells were then washed and analyzed by FACS. FACS was performed using an antibody speciﬁc for the activated
p38 MAPK (phospho-p38 [p-p38]). The results are shown for events in the live cell gate and are representative of at least three independent experiments. (B) Western blots
using a phospho-p38-speciﬁc antibody (left) were performed on protein derived from human T cells cultured either in medium alone or treated with CXCL10 + IL-2 + IFNa, for
the times indicated. The phosphorylation was quantiﬁed by chemiluminescence and standardized against the same blots stripped and re-probed with antibodies that
recognize total p38 protein. Actin was used as a loading control. Western blots and band quantiﬁcation (right) in T cells that were untreated or cultured with IL-2, IFNa,
CXCL10, or a combination of the three, as indicated, for 16 h. Cells were then lysed and phosphorylation of p38 was determined by western blot analysis using speciﬁc anti-
phospho-p38 antibodies.
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using antibodies that recognize both procaspase 3 (p32) and
cleaved CASP3 (p19, p17 and p12). As shown in Fig. 2D, indepen-
dent treatments with CXCL10 or IL-2 or IFNa did not result in
appreciable CASP3 overexpression or cleavage. It was the com-
bined treatment with CXCL10 + IL-2 + IFNa that caused the highest
levels of CASP3 activation, closely followed by CXCL10 + IL-2. Inter-
estingly, treatment with IL-2 + IFNa also resulted in CASP3
activation.3.3. CXCL10 induces sustained activation of p38 MAPK pathways in T
cells
To elucidate the signaling pathways responsible for CXCL10-
mediated apoptosis, we studied the phosphorylation of different
MAPK kinases, which are essential signaling mediators that lead
cells toward apoptosis or survival. First we examined the putative
role of CXCL10 as an activator of p38 MAPK in activated T lympho-
cytes by ﬂow cytometric analysis using phospho-speciﬁc antibodies
andwestern blotting, (Fig. 3A).We found that CXCL10 treatment re-
sulted in rapid and sustained phosphorylation of p38. The maximal
response was observed within 60 min following CXCL10 stimula-
tion and continued for 24 h (Fig. 3B). We also observed that CXCL10
alone, but not IFNa or IL-2, was able to induce modest p38 phos-
phorylation. It was the combined treatment with CXCL10 and IL-2
that caused a dramatic increase in the phosphorylation levels ofp38, which is in accordance with the induction of the abovemen-
tioned apoptosis.3.4. CXCL10 induces transient phosphorylation of Akt and p44/p42 ERK
in T lymphocytes
Later, we investigated Akt phosphorylation after stimulation of
T lymphocytes with CXCL10 + IL2 + IFNa by FACS analysis. CXCL10
(50 nM) induced a transient, time-dependent increase in Akt phos-
phorylation, reaching the maximum levels in 15 min and returning
close to the basal levels in the 60-min time-point (Fig. 4A). When
using a lower concentration of CXCL10 (10 nM), the phosphoryla-
tion peak was detected after 45 min of incubation, and the levels
were still high 60 min after the beginning of the stimulation (data
not shown). These ﬁndings were conﬁrmed using western blot
analysis (Fig. 4B). Our results also suggest that CXCL10-mediated
Akt phosphorylation is stronger when IL-2 and/or IFNa are present
(Fig. 4B). Next, we examined the activation of the p44/p42 ERK ki-
nases following exposure of peripheral T cells to CXCL10 + IL2 + IF-
Na. Exposure of CXCR3-expressing lymphocyte cells to CXCL10
(50 nM) resulted in a transient increase in p44/p42 ERK phosphor-
ylation which peaked after 30 min of exposure to CXCL10 (Fig. 5A
and B). However, in the assay where different combinations of
cytokines were tested, the incubation time was too long (16 h)
and the ERK phosphorylation was indistinguishable from the basal
activation (Fig. 5B), indicating that the transient ERK activation had
already extinguished. However, considering the other assays
Fig. 4. CXCL10 induces transient activation (phosphorylation) of AKT MAPK in CXCR3-positive T lymphocytes. A) Freshly isolated human T cells were cultured in medium
alone, or treated with IL-2 or IFNa or CXCL10, or with a combination of all three for the times indicated. Cells were then washed and analyzed by FACS. FACS was performed
for activated AKT MAPK (phospho-AKT [p-AKT]). FACS results are shown for events in the live cell gate and are representative of at least three independent experiments. Left:
histogram analysis of intracellular staining of p-AKT in CXCR3+ cells. Right: mean ﬂuorescent intensity of p-AKT in T cells. B) Left: human T cells were cultured in medium
alone or treated with IL-2, IFNa, and CXCL10 for the times indicated. Cells were then lysed and phosphorylation levels of AKT were determined by western blot analysis using
speciﬁc anti-phospho-p38 antibodies. Phosphorylation was quantiﬁed by chemiluminescence and corrected for total AKT MAPK expression on the strip blot. Total AKT and
actin were used as loading controls. Right, T cells were untreated or treated with IL-2 or IFNa or CXCL10, or in combination, as indicated for16 h; phosphorylation of p38 was
determined by western blot analysis using speciﬁc anti-phospho-AKT antibodies.
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stronger when CXCL10 incubation occurs in combination with IL-2
and/or IFNa.3.5. Evaluation of the implication of different signaling mediators in
apoptosis and survival by using speciﬁc inhibitors
Human primary T lymphocytes were incubated with
CXCL10 + IL-2 + IFNa together with different pathway-speciﬁc
inhibitors, and after 24 h, the percentage of cell death was deter-
mined by FACS analysis (Fig. 6). As expected, cells treated with
CXCL10 + IL-2 + IFNa, but not inhibitors, showed a notable increase
in cell death as compared with the untreated cells (medium only).
Both pertussis toxin (inhibitor of G-coupled protein signaling) and
wortmannin (PI3K inhibitor) induced a signiﬁcant increase in the
percentage of cell death as compared with the no-inhibitors group.
On the other hand, cells treated with SB203580 (p38 MAPK inhib-
itor) showed similar levels of cell death as the untreated group
(medium only), indicating that the inhibitor was able to revert
the apoptosis induced by CXCL10 + IL-2 + IFNa. Finally, the inhibi-
tor PD98509 (MEK inhibitor, upstream of ERK) did not modify the
levels of cell death as compared with the no-inhibitor group, sug-
gesting that the activation of p44/p42 ERK is not connected with
the induction of either cell death or survival. Additionally, T
lymphocytes were treated separately with all the inhibitors and
no increase in the levels of apoptosis was observed for any of them
(data not shown).3.6. CXCL10 blocks Bcl2 anti-apoptotic activity by inducing its
phosphorylation in T cells via p38 MAPK
To investigate the anti-apoptotic activity of Bcl2 upon treat-
ment with CXCL10 + IL-2 + IFNa, we performed western blots on
whole cell lysates of T cells, using antibodies that recognized both
phosphorylated and total Bcl2. As shown in Supp. Fig. 3A, we were
unable to detect changes in the expression levels of the Bcl2 pro-
tein, whose upregulation is normally linked with the presence of
stronger anti-apoptotic signals. However, phosphorylated Bcl2
was present in CXCL10-treated T cells, but not in medium-only
cells. This suggests that the treatment with CXCL10 in activated
T lymphocytes blocks, at least in part, the anti-apoptotic activity
of Bcl2 by phosphorylation, which can be exerted by active p38
MAPK.
4. Discussion
The expression of CXCL10 is part of the interferon-stimulated
genes (ISGs) response and its presence is one of the hallmarks of
the immune responses during viral infections [2]. During a self-
limited inﬂuenza infection process, high levels of CXCL10 can be
detected during the early stages of the disease, and shortly after
the virus has been cleared CXCL10 returns to its basal levels, even
though other markers of inﬂammation and repair may remain
elevated beyond that point [1]. On the other hand, in situations
where the host fails to control the viral infection the levels of
CXCL10, together with other ISGs and inﬂammatory mediators,
Fig. 5. CXCL10 induces activation (phosphorylation) of p44/42 ERK in CXCR3-positive T lymphocytes. (A) Freshly isolated human T cells were cultured in medium alone, or
treated with IL-2 or IFNa or CXCL10 or with a combination of all three for the times indicated. Cells were then washed and analyzed by FACS. FACS was performed for
activated p44/p42 ERK (phospho-ERK [p-ERK]). FACS results are shown for events in the live cell gate and are representative of at least three independent experiments. Left:
histogram analysis of intra-cellular staining of p-ERK in CXCR3 + lymphocytes. Right: mean ﬂuorescent intensity of p-ERK in T cells. (B) CXCL10 induces phosphorylation of
p44/p42 ERK in T lymphocytes: (left) human T cells were cultured in medium alone or treated with IL-2, IFNa, and CXCL10 for the times indicated. Cells were then lysed and
phosphorylation levels of ERK were determined by western blot analysis using speciﬁc anti-phospho-ERK antibodies. Phosphorylation was quantiﬁed by chemiluminescence
and corrected for total p44/p42 ERK expression on strip blot; total ERK and actin were used as loading controls (right). T cells were untreated or treated with IL-2 or IFNa or
CXCL10, or a combination of the three, as indicated, for16 h; phosphorylation of ERK was determined by western blot analysis using speciﬁc anti-phospho-ERK antibodies.
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detrimental effects by means of excessive immune activation and
cell death [22]. We found that CXCL10 alone is a very modest
inducer of apoptosis (according to the Annexin V results). Conse-
quently, we needed to consider the addition of other lymphocyte
activators that are present during antiviral responses in vivo to un-
leash the full potential of CXCL10. Since CXCL10 shows its true bio-
logical effects in combination with other cytokines, such as IL2 and
IFNa, the signaling status upon treatment with this combination of
cytokines was the focus of our study. It can be argued that the ob-
served downstream signaling might not correspond to a pure
CXCL10 response and some of the observed effects might be over-
lapping with those from IL2 or IFNa. On the other hand, it should
be noted that the presence of these cytokines during viral infec-
tions is a proven fact that merits scientiﬁc attention, while an
in vivo response mediated by CXCL10 alone is an unlikely scenario.
CXCR3 is a seven-transmembrane-spanning domain glycopro-
tein receptor that is coupled to a G-protein signaling pathway.
Binding of different chemokines to CXCR3, such as CXCL4, CXCL9,
CXCL10 and CXCL11, causes downstream activation of phospholi-
pase C (PLC), kinase A and C, formation of phosphatidyl inositol-
1,4,5-triphophate, and increases intracellular calcium ions [7,23].
Here we have conﬁrmed that CXCR3 is expressed on blood T lym-
phocytes and its expression is greatly enhanced by IL-2 treatment
[6] (Fig. 1). Moreover, we showed that IFNa treatment signiﬁcantly
increases the expression of CXCL10 in T cells and HEK239 cells(Supp. Fig. 2); however, CXCL10 does not induce changes in the
expression of its receptor, CXCR3 (Fig. 1C and D). Our observations
are in accordance with previous studies which revealed that CXCR3
expression in T lymphocytes is ﬁne-tuned and it is determined by
the presence of certain cytokines [24]. It would appear that both
CXCR3 + and CXCR3- populations of cells are undergoing apoptosis.
While IL2 did not cause a detectable increase in the level of apop-
tosis (Annexin V) or CASP3 activation (Fig. 2C and D), CXCL10 and
INFa each alone caused a modest increase in apoptosis. The dual
combination of Il-2 plus IFNa induced substantially greater levels
of apoptosis, and the combination of CXCL10 and IL-2 and the
triple combination of IL-2, IFNa and CXCL10 induced the highest
levels of apoptosis. Therefore, it is likely that CXCL10 responsive
CXCR3+ and CXCR3- cells are undergoing apoptosis.
Chemotaxis is the best-known CXCR3-mediated effect in leuko-
cytes, and the activation of this signaling pathway can be inhibited
by pertussis toxin [8]. Our results and also previous studies have
shown that CXCL10 and other CXCR3 ligands induce activation of
p38 MAPK [11] (Fig. 3), PI3K/Akt [5,8] (Fig. 4) and p44/42 ERK
(Fig. 5). However, studies with small molecule kinase inhibitors
were unable to link conclusively these kinases with the induction
of chemotaxis in T lymphocytes [8], although some evidence of
the involvement of kinase-mediated signaling has been provided
[11]. Smit et al. proposed that chemotaxis is not mediated by
ERK or Akt but rather by phospholipase C-dependent pathways
and phosphatidylinositol kinases other than PI3Kc [8].
Fig. 6. CXCL10 mediated death of T cells via initiation of proapoptotic signals. T
lymphocytes were untreated or treated with a combination of IL-2, IFNa, and
CXCL10, following separate pre-incubations with the following inhibitors: pertussis
toxin (inhibits G-protein coupled signaling), wortmannin (PI3K inhibitor),
SB203580 (p38 MAPK inhibitor), and PD98509 (MEK inhibitor). 24 h later, the
percentage of T cell death was determined using an Annexin V-PE Apoptosis
Detection Kit (BD Biosciences).
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decided to explore its implication in the induction of apoptosis
and to delineate the signaling pathways that are involved in the
process. Our results show that CXCL10 contributes to the triggering
of apoptosis in activated human T lymphocytes, as shown by
Annexin V-PE staining (Fig. 2A–C). To determine whether cell
death was CASP3-mediated, we analyzed whole cell lysates from
T lymphocytes treated with CXCL10 + IL-2 + IFNa for the presence
of active and cleaved fragments of CASP3 using western blotting
probed with antibodies that recognize both procaspase 3 (p32)Fig. 7. Proposed model of CXCL10 functions during lymphocyte activation. During
viral infections and other insults, CXCL10 is produced in response to interferon
signaling. IL-2, which is also part of the early immune response, augments the
proportion of CXCR3-expressing T lymphocytes and increases their responsiveness.
CXCL10 binds its receptor CXCR3, and through transient phosphorylation of Akt and
p44/p42 ERK, CXCL10 participates in T lymphocyte activation, survival, prolifera-
tion, differentiation and chemotaxis toward the infection sites. However, additional
co-signaling is required to maintain long-standing activation, and without it,
CXCL10 induces p38-mediated apoptosis, which causes the elimination of low-
afﬁnity T lymphocyte subsets.and cleaved CASP3 (p19, p17 and p12). As shown in Fig. 2D, inde-
pendent treatments with CXCL10 or IL-2 or IFNa did not result in
appreciable CASP3 overexpression or cleavage. The highest levels
of CASP3 activation resulted only with the combined treatment
with CXCL10 + IL-2 + IFNa, closely followed by CXCL10 + IL-2 treat-
ment. Interestingly, treatment with IL-2 + IFNa also resulted in
CASP3 activation but at much lower levels.
We found that CXCL10 induces sustained phosphorylation of
p38 MAPK in T lymphocytes (Fig. 3), a critical mediator of apopto-
sis that also participates in other cellular processes, including
inﬂammation, cell differentiation, and cell growth [25]. Moreover,
in our study we have shown that CXCL10-induced apoptosis was
abrogated by the p38 inhibitor SB203580 (Fig. 6), which conﬁrms
the role of p38 in the pro-apoptotic signaling during incubation
with CXCL10. The anti-apoptotic Bcl2 has been identiﬁed as a
p38 MAPK substrate [26], and by direct phosphorylation of Bcl2,
p38 MAPK prevents Bcl2 from exerting its anti-apoptotic function
and allows the apoptotic process to occur [27]. Our results did not
clearly show any changes in the expression levels of Bcl2 upon
incubation of T lymphocytes with CXCL10 + IL2 + IFNa; however,
the phosphorylated form of Bcl2 was more prominent in the che-
mokine-treated group (Supp. Fig. 3) which conﬁrms the activity
of p38 MAPK.
Induction of cell survival is also a critical role of CXCL10 and
other CXCR3 ligands. We found that pertussis toxin dramatically
increased the rate of apoptotic T cells treated with CXCL10 + I-
L2 + IFNa, indicating that anti-apoptotic signals are G-protein
dependent (Fig. 6); also, pre-treatment of T cells with wortmannin
(PI3K inhibitor) led to a signiﬁcant increase in cell death (Fig. 6).
The controls treated only with either pertussis toxin or wormannin
did not show increased levels of apoptosis (data not shown), ruling
out the possibility that these inhibitors triggered pro-apoptotic sig-
nals directly. These results show that CXCR3-mediated signaling
plays a critical role in the induction of pro-survival signals in acti-
vated T lymphocytes; however, the exact mechanism requires fur-
ther investigation. Later, we studied the activation proﬁle of Akt,
which is a downstream signaling mediator of PI3K. Akt was found
to be phosphorylated in T lymphocytes treated with CXCL10 to-
gether with IL2 and/or IFNa, and its activation was found to be
transient; strong Akt phosphorylation can be detected as early as
5 min after stimulation and it is barely detectable after 60 min
(Fig. 4). Akt is crucial for cell survival, proliferation, gene expres-
sion and cell migration [8], and the pro-survival effects are ex-
plained, at least in part, by the fact that Akt inactivates the
apoptotic factor BAD by direct phosphorylation [28]. PI3K and
downstream activation of Akt are closely related; however, addi-
tional studies are required to elucidate some aspects of their asso-
ciation, such as the involvement of other PI3K downstream
signaling mediators, the mechanism through which Akt phosphor-
ylation is rapidly ended, or the conditions that would be necessary
for sustained Akt activation. As previously demonstrated for
CXCL12 and CXCR4, the loss of Akt signaling after transient activa-
tion may be the triggering event for chemokine-induced apoptosis
[8,18]. This process might be required not only to promote cell
migration, but also to induce programmed cell death in T cells
when CXCR3 ligands are highly expressed. As mentioned above,
we found that CXCL10 induced transient phosphorylation of ERK
in activated T lymphocytes; however, pretreatment of T cells with
the MAPK kinase (MEK) inhibitor PD98059 (MEK is an upstream
regulator of p44/p42 ERK) does not alter the percentage of apopto-
tic cells (Fig. 6), suggesting that CXCL10-induced activation of p44/
p42 ERK does not play a relevant role in the survival/apoptosis sig-
naling. Taken together, these results highlight the relevance of
G-coupled chemokine receptor signaling to promote survival dur-
ing lymphocyte activation, a mechanism in which the downstream
signaling is mediated by PI3K and Akt.
A.M.E. Sidahmed et al. / Cytokine 59 (2012) 433–441 441In this study, In vitro experiments have shown that CXCL10
induces p38-mediated apoptosis in a relevant proportion of T
lymphocytes (Fig. 2), and at the same time, CXCL10 + IL2 + IFNa
treatment promotes cell survival through PI3K and Akt activation.
In vivo, CXCL10 participates in the activation of T lymphocytes
during viral infections by priming toward the Th1 phenotype and
inducing chemotaxis toward the infected tissues, however, the
biological role of CXCL10 as modulator of apoptosis and survival
in T lymphocytes is still unclear. We speculate that CXCL10 may
help to focus the adaptive immune responses by inducing apopto-
sis of low-afﬁnity T lymphocyte subsets [29,30], including those
lymphocytes that initially were activated but later lacked the
appropriate sets of speciﬁc co-stimulating signals to ensure their
survival (Fig. 7). Additional studies in terms of cell maturity, anti-
gen selectivity, and Th1/Th2 phenotype are required to delineate
the features of the T lymphocytes that are positively selected by
CXCL10 from those which are depleted by apoptosis in the context
of a viral infection.
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